Monica Moresco

Monica Moresco

Auto-generated profile, based on publicly available information

Monica Moresco

IRCCS Istituto delle Scienze Neurologiche di Bologna Bologna Italy

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2019 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
PDF file
EAElena Antelmi
Elena Antelmi
FPFabio Pizza
Fabio Pizza
VDVincenzo Donadio
Vincenzo Donadio
Marco FilardiMarco Filardi
Marco Filardi
YSYuri L. Sosero
Yuri L. Sosero
Giuseppe PlazziGiuseppe Plazzi
Giuseppe Plazzi
To search for discriminating biomarkers, 30 patients with idiopathic rapid‐eye‐movements sleep behavior disorder (iRBD) were compared with 17 patients with RBD within narcolepsy type 1. Both groups underwent extensive examinations, including skin biopsy searching for phosphorylated α‐synuclein deposits and whole‐night video‐polysomnography. Skin biopsy was positive for phosphorylated α‐synuclein deposits in 86.7% of iRBD patients and in none of narcoleptic patients. The analysis of video‐polysomnographic motor events showed differences in their occurrence throughout the night in the two groups. iRBD and RBD due to narcolepsy do have different clinical and pathological findings, confirming a different pathophysiology.

30 October 2018 in Neurology
Verified
Journal Article
Closed access
PDF file
Stefania MondelloStefania Mondello
Stefania Mondello
Firas KobeissyFiras Kobeissy
Firas Kobeissy
Yehia MechrefYehia Mechref
Yehia Mechref
JZJingfu Zhao
Jingfu Zhao
FTFarid R. Talih
Farid R. Talih
RFRaffaele Ferri
Raffaele Ferri
Objective To perform a rigorous in-depth proteomics analysis to identify circulating biomarker signatures for idiopathic REM sleep behavior disorder (RBD), capable of providing new insights into the underlying pathogenic mechanisms and putative a-synuclein-related neurodegenerative processes. Methods Serum samples from patients with idiopathic RBD (n = 9) and healthy controls (n = 10) were subjected to a thorough liquid chromatography-mass spectrometry (MS)/MS proteomics analysis using ultimate 3,000 nanoLC interfaced to an ESI-orbitrap velos. Data were analyzed with a systems biology approach to identify altered pathways in RBD. Results We identified 259 proteins, 11 of which displayed significantly altered expression level in patients with RBD as compared to controls. Significant reduction in serum levels of dopamine beta-hydroxylase (DBH) and vitamin D binding protein (GC) were consistent with alterations in the norepinephrinergic (NErgic) and dopaminergic systems, respectively. Additional altered protein profiles indicated that immunity, inflammation, complement, and coagulation also play a role in RBD pathophysiology. Conclusions Our results shed light on the protein signature profile, molecular pathways, and mechanisms involved in the pathogenesis of RBD and its clinical manifestation. This knowledge opens a new avenue towards more accurate and timely diagnosis and characterization of RBD, which might ultimately translate into new therapeutic strategies with disease-modifying effects. Further evaluation of the identified markers is required to confirm their diagnostic value and potential to guide clinical decision-making.

29 July 2019 in SLEEP
Verified
Journal Article
Closed access
SVStefano Vandi
Stefano Vandi
SRSara Rodolfi
Sara Rodolfi
FPFabio Pizza
Fabio Pizza
MMMonica Moresco
Monica Moresco
EAElena Antelmi
Elena Antelmi
Alessandro SilvaniAlessandro Silvani
Alessandro Silvani
Study Objectives: Arterial blood pressure (ABP) decreases during sleep compared with wakefulness and this change is blunted in mouse models of and adult patients with narcolepsy type 1 (NT1). We tested whether: (1) pediatric patients with NT1 have similar cardiovascular autonomic abnormalities during nocturnal sleep; and (2) these abnormalities can be linked to hypocretin-1 cerebrospinal fluid concentration (CSF HCRT-1), sleep architecture, or muscle activity.Methods: Laboratory polysomnographic studies were performed in 27 consecutive drug-naïve NT1 children or adolescents and in 19 matched controls. Nocturnal sleep architecture and submentalis (SM), tibialis anterior (TA), and hand extensor (HE) electromyographic (EMG) activity were analyzed. Cardiovascular autonomic function was assessed through the analysis of pulse transit time (PTT) and heart period (HP).Results: PTT showed reduced lengthening during total sleep and REM sleep compared with nocturnal wakefulness in NT1 patients than in controls, whereas HP did not. NT1 patients had altered sleep architecture, higher SM EMG during REM sleep, and higher TA and HE EMG during N1–N3 and REM sleep when compared with controls. PTT alterations found in NT1 patients were more severe in subjects with lower CSF HRCT-1, but did not cluster or correlate with sleep architecture alterations or muscle overactivity during sleep.Conclusion: Our results suggest that pediatric NT1 patients close to disease onset have impaired capability to modulate ABP as a function of nocturnal wake–sleep transitions, possibly as a direct consequence of hypocretin neuron loss. The relevance of this finding for cardiovascular risk later in life remains to be determined.

15 November 2017 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
LFLorenzo Ferri
Lorenzo Ferri
Marco FilardiMarco Filardi
Marco Filardi
MMMonica Moresco
Monica Moresco
FPFabio Pizza
Fabio Pizza
SVStefano Vandi
Stefano Vandi
Giuseppe PlazziGiuseppe Plazzi
Giuseppe Plazzi
We report the case of a 14-year-old girl with a wide non-compressive pineal cyst, associated with the inability to control her sleep-wake schedule. Actigraphic monitoring showed a 24-hour free-running disorder (tau 26.96 hours). A 24-hour serum melatonin curve assay, with concomitant video-polysomnographic and body-core temperature monitoring, was performed. Melatonin curve showed a blunted nocturnal peak, lower total quantity of melatonin, and prolonged melatonin secretion in the morning, with normal temperature profile and sleep parameters. Treatment with melatonin up to 14 mg at bedtime was initiated with complete realignment of the sleep-wake rhythm (tau 23.93 hours). The role of the pineal cyst in the aforementioned alteration of melatonin secretion and free-running disorder remains controversial, but our case supports the utility of monitoring sleep/wake, temperature, and melatonin rhythms in the diagnostic work-up of pineal cysts associated with free-running disorder.

28 November 2020 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
EPEmanuela Postiglione
Emanuela Postiglione
FPFabio Pizza
Fabio Pizza
FIFrancesca Ingravallo
Francesca Ingravallo
LVLuca Vignatelli
Luca Vignatelli
Marco FilardiMarco Filardi
Marco Filardi
Giuseppe PlazziGiuseppe Plazzi
Giuseppe Plazzi
Study Objectives: Narcolepsy type 1 (NT1) is a chronic rare hypersomnia of central origin requiring a combination of behavioral and pharmacological treatments. During the coronavirus disease 2019 (COVID‐19) pandemic, in Italy the population was forced into a lockdown. With this study, we aimed to describe the lockdown impact on NT1 symptom management, according to different patients' working schedule.Methods: In the period between 10 April and 15 May 2020, we performed routine follow‐up visits by telephone (as recommended during the COVID‐19 emergency) to 50 patients >18 years old (40% males) under stable long‐term treatment. We divided patients into three groups: unchanged working schedule, forced working/studying at home, and those who lost their job (“lost occupation”). Current sleep–wake habit and symptom severity were compared with prelockdown assessment (six months before) in the three patient groups.Results: At assessment, 20, 22, and eight patients belonged to the unchanged, working/studying at home, and lost occupation groups, respectively. While in the lost occupation group, there were no significant differences compared with prepandemic assessment, the patients with unchanged schedules reported more nocturnal awakenings, and NT1 patients working/studying at home showed an extension of nocturnal sleep time, more frequent daytime napping, improvement of daytime sleepiness, and a significant increase in their body mass index. Sleep‐related paralysis/hallucinations, automatic behaviors, cataplexy, and disturbed nocturnal sleep did not differ.Conclusions: Narcolepsy type 1 patients working/studying at home intensified behavioral interventions (increased nocturnal sleep time and daytime napping) and ameliorated daytime sleepiness despite presenting with a slight, but significant, increase of weight.

1 April 2018 in Sleep Medicine
Verified
Journal Article
Closed access
MMMonica Moresco
Monica Moresco
MLMariangela Lecciso
Mariangela Lecciso
DODarina Ocadlikova
Darina Ocadlikova
Marco FilardiMarco Filardi
Marco Filardi
SMSilvia Melzi
Silvia Melzi
Giuseppe PlazziGiuseppe Plazzi
Giuseppe Plazzi